These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 9815570
41. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J. Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [Abstract] [Full Text] [Related]
42. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y. Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042 [Abstract] [Full Text] [Related]
43. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome. Huang LW, Chou YY, Chao SL, Chen TJ, Lee TT. Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096 [Abstract] [Full Text] [Related]
44. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. Sarkaria IS, Pham D, Ghossein RA, Talbot SG, Hezel M, Dudas ME, Ebright MI, Chuai S, Memoli N, Venkatraman ES, Miller VA, Kris MG, Zakowski MF, Rusch VW, Singh B. Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464 [Abstract] [Full Text] [Related]
45. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK. Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):822-9. PubMed ID: 15465199 [Abstract] [Full Text] [Related]
46. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma]. Zhang H, Lü F, Yue W, Yan H, Deng L, Wang S. Zhonghua Bing Li Xue Za Zhi; 2000 Oct 01; 29(5):328-30. PubMed ID: 11866928 [Abstract] [Full Text] [Related]
47. [Clinical significance of oncogene product expression in human lung cancer]. Dosaka-Akita H, Harada M, Miyamoto H, Kawakami Y. Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug 01; 30(8):1441-7. PubMed ID: 1331597 [Abstract] [Full Text] [Related]
48. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer. Chyczewski L, Nikliński J, Chyczewska E, Laudański J, Furman M. Rocz Akad Med Bialymst; 1997 Aug 01; 42 Suppl 1():162-72. PubMed ID: 9337534 [Abstract] [Full Text] [Related]
49. [Pathological variability and cancer treatment in lung cancer]. Kodama T. Gan To Kagaku Ryoho; 1986 Sep 01; 13(9):2708-17. PubMed ID: 3019250 [Abstract] [Full Text] [Related]
51. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test. Scheurle D, Jahanzeb M, Aronsohn RS, Watzek L, Narayanan R. Anticancer Res; 2000 Mar 01; 20(3B):2091-6. PubMed ID: 10928158 [Abstract] [Full Text] [Related]
52. p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival. Caputi M, Esposito V, Baldi A, De Luca A, Dean C, Signoriello G, Baldi F, Giordano A. Am J Respir Cell Mol Biol; 1998 Feb 01; 18(2):213-7. PubMed ID: 9476908 [Abstract] [Full Text] [Related]
53. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer]. Kosacka M, Jankowska R. Pneumonol Alergol Pol; 2007 Feb 01; 75(4):317-23. PubMed ID: 18080980 [Abstract] [Full Text] [Related]
54. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung. Komiya T, Hirashima T, Takada M, Masuda N, Yasumitsu T, Nakagawa K, Hosono Y, Kikui M, Tsuji S, Fukuoka M, Kawase I. Anticancer Res; 1997 Feb 01; 17(5B):3721-4. PubMed ID: 9427768 [Abstract] [Full Text] [Related]
55. Adenosquamous lung carcinomas: a histologic subtype with poor prognosis. Filosso PL, Ruffini E, Asioli S, Giobbe R, Macri L, Bruna MC, Sandri A, Oliaro A. Lung Cancer; 2011 Oct 01; 74(1):25-9. PubMed ID: 21371773 [Abstract] [Full Text] [Related]
56. Clinical significance of p21 expression in non-small-cell lung cancer. Shoji T, Tanaka F, Takata T, Yanagihara K, Otake Y, Hanaoka N, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S, Katakura H, Wada H. J Clin Oncol; 2002 Sep 15; 20(18):3865-71. PubMed ID: 12228206 [Abstract] [Full Text] [Related]
57. Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Cooke DT, Nguyen DV, Yang Y, Chen SL, Yu C, Calhoun RF. Ann Thorac Surg; 2010 Sep 15; 90(3):943-8. PubMed ID: 20732522 [Abstract] [Full Text] [Related]
58. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Xie X, Clausen OP, Boysen M. Arch Otolaryngol Head Neck Surg; 2002 Aug 15; 128(8):897-902. PubMed ID: 12162767 [Abstract] [Full Text] [Related]
59. Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung. Danner BC, Hellms T, Jung K, Gunawan B, Didilis V, Füzesi L, Schöndube FA. Ann Thorac Surg; 2011 Sep 15; 92(3):1038-43. PubMed ID: 21871296 [Abstract] [Full Text] [Related]
60. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, Beck AF, Hyland A, Todorov IT, Brooks JS, Bepler G. J Clin Oncol; 2001 Nov 15; 19(22):4259-66. PubMed ID: 11709570 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]